Published in Genomics and Genetics Weekly, March 4th, 2005
Total kit sales of Fuzeon in the U.S. and Canada for the fourth quarter of 2004 were approximately 17,200 kits compared to approximately 14,600 kits in the third quarter of 2004, an increase of approximately 18%. Net sales of Fuzeon outside the U.S. and Canada were $15.6 million during the fourth quarter of 2004, compared to $13.1 million during the third quarter of 2004, an increase of 19%. All sales of Fuzeon are recorded by Roche, Trimeris'...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Genomics and Genetics Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.